270 related articles for article (PubMed ID: 12084939)
1. Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation.
Moon C; Yoo JY; Matarazzo V; Sung YK; Kim EJ; Ronnett GV
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):9015-20. PubMed ID: 12084939
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor mRNA expression is upregulated in macrophages and olfactory receptor neurons after target ablation.
Getchell TV; Shah DS; Partin JV; Subhedar NK; Getchell ML
J Neurosci Res; 2002 Jan; 67(2):246-54. PubMed ID: 11782968
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells.
Boeuf H; Hauss C; Graeve FD; Baran N; Kedinger C
J Cell Biol; 1997 Sep; 138(6):1207-17. PubMed ID: 9298977
[TBL] [Abstract][Full Text] [Related]
4. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
Schuringa JJ; van der Schaaf S; Vellenga E; Eggen BJ; Kruijer W
Exp Cell Res; 2002 Mar; 274(1):119-29. PubMed ID: 11855863
[TBL] [Abstract][Full Text] [Related]
5. Expression of CNTF/LIF-receptor components and activation of STAT3 signaling in axotomized facial motoneurons: evidence for a sequential postlesional function of the cytokines.
Haas CA; Hofmann HD; Kirsch M
J Neurobiol; 1999 Dec; 41(4):559-71. PubMed ID: 10590179
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
Tone E; Kunisada K; Fujio Y; Matsui H; Negoro S; Oh H; Kishimoto T; Yamauchi-Takihara K
Biochem Biophys Res Commun; 1998 Dec; 253(1):147-50. PubMed ID: 9875235
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptors control competence to interpret leukemia inhibitory factor as an astrocyte inducer in developing cortex.
Viti J; Feathers A; Phillips J; Lillien L
J Neurosci; 2003 Apr; 23(8):3385-93. PubMed ID: 12716946
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
9. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
Bousquet C; Melmed S
J Biol Chem; 1999 Apr; 274(16):10723-30. PubMed ID: 10196143
[TBL] [Abstract][Full Text] [Related]
10. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor promotes olfactory sensory neuronal survival via phosphoinositide 3-kinase pathway activation and Bcl-2.
Moon C; Liu BQ; Kim SY; Kim EJ; Park YJ; Yoo JY; Han HS; Bae YC; Ronnett GV
J Neurosci Res; 2009 Apr; 87(5):1098-106. PubMed ID: 19021297
[TBL] [Abstract][Full Text] [Related]
12. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
14. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
15. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.
Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K; Miyake A; Murata Y
Endocrinology; 1997 Jul; 138(7):2689-96. PubMed ID: 9202205
[TBL] [Abstract][Full Text] [Related]
16. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation.
Cheng JG; Chen JR; Hernandez L; Alvord WG; Stewart CL
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8680-5. PubMed ID: 11438698
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
Turnley AM; Faux CH; Rietze RL; Coonan JR; Bartlett PF
Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
[TBL] [Abstract][Full Text] [Related]
18. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.
Mynard V; Guignat L; Devin-Leclerc J; Bertagna X; Catelli MG
Endocrinology; 2002 Oct; 143(10):3916-24. PubMed ID: 12239103
[TBL] [Abstract][Full Text] [Related]
19. Promotion of the development of enteric neurons and glia by neuropoietic cytokines: interactions with neurotrophin-3.
Chalazonitis A; Rothman TP; Chen J; Vinson EN; MacLennan AJ; Gershon MD
Dev Biol; 1998 Jun; 198(2):343-65. PubMed ID: 9659938
[TBL] [Abstract][Full Text] [Related]
20. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland.
Kritikou EA; Sharkey A; Abell K; Came PJ; Anderson E; Clarkson RW; Watson CJ
Development; 2003 Aug; 130(15):3459-68. PubMed ID: 12810593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
